Fsm Wealth Advisors, LLC Bristol Myers Squibb CO Transaction History

Fsm Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $50,379 - $57,120	1,050 Added 18.71%	6,661 $361,000
Q4 2023 May 14, 2024	BUY	$48.48 - $57.85 $7,611 - $9,082	157 Added 2.88%	5,611 $287,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $65,878 - $73,662	-1,138 Reduced 17.26%	5,454 $316,000
Q2 2023 Jul 12, 2023	BUY	$63.71 - $70.74 $76,133 - $84,534	1,195 Added 22.14%	6,592 $421,000
Q1 2023 Apr 24, 2023	BUY	$65.71 - $74.53 $76,552 - $86,827	1,165 Added 27.53%	5,397 $374,000
Q4 2022 Jan 19, 2023	SELL	$68.48 - $81.09 $78,341 - $92,766	-1,144 Reduced 21.28%	4,232 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $221 - $131,089	1,706 Added 46.49%	5,376 $382,000
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $266,515 - $293,526	3,670 New	3,670 $271,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fsm Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fsm Wealth Advisors, LLC with notifications on news.